Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of oliceridine combined with ciprofol for analgesia in outpatient hysteroscopic surgery
ChiCTR2500103736Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical University
- Start
- Jun 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine and ciprofol, sponsored by The First Affiliated Hospital of Xinxiang Medical University. Primary endpoints: Oliceridine dosage, Total ciprofol dosage and 3 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
oliceridineciprofol
Beyond the preview
Go deeper on ChiCTR2500103736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103736.